OMAHA, NE - January 22, 2026 - PRESSADVANTAGE - Modern Vision Solutions has announced the publication of a new article, ...

Xdemvy (lotilaner ophthalmic solution 0.25%) is a medicine designed to treat Demodex blepharitis, a common but often overlooked eye condition caused by microscopic insects called Demodex mites on the ...

I. Benjamin Gaddie, OD, FAAO, summarized the best forms of treating and managing demodex blepharitis. First of all, making the diagnosis is the seminal event in demodex blepharitis, and it's really ...

Demodex blepharitis is more common than most people realize—but with the right treatment, it doesn’t have to be a lifelong nuisance. “You only get one pair of eyes,” Dr. Yeu says. “And this is one ...

XDEMVY (lotilaner ophthalmic solution) 0.25%, formerly known as TP-03, is a novel prescription eye drop designed to treat Demodex blepharitis by targeting and eradicating the root cause of the disease ...

Demodex blepharitis is a highly prevalent, yet often undiagnosed eyelid disease that impacts approximately 25 million eye care patients in the U.S. “We know that many patients struggle with eyelid ...

The Demodex mite is a ubiquitous microscopic ectoparasite that colonises the pilosebaceous units on human skin, notably the eyelids, where it may contribute to conditions such as blepharitis and ...

Demodex blepharitis is a highly prevalent, yet often undiagnosed eyelid disease that impacts approximately 25 million eye care patients in the U.S. IRVINE, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- ...